The import of carboxyamid-function compounds to China is forecasted to grow steadily from 2024 to 2028, with values increasing from $1.1355 billion in 2024 to $1.301 billion by 2028. This upward trend highlights a consistent year-on-year growth rate, signaling a robust demand in the Chinese market. Compared to 2023, this forecasted growth shows a strong inclination towards expanding the import of these compounds, as the market seeks to fulfill industrial and pharmaceutical needs. The average compound annual growth rate (CAGR) for this period adds a layer of strategic insight, indicating a healthy expansion of imports over these years.
Future trends to watch for include potential shifts in global trade policies, advancements in domestic production capabilities in China, and technological innovations in the chemical sector that might affect import demand. Additionally, monitoring changes in environmental regulations and sustainability pushes could also influence future import volumes and values.
